Compound Detail
CHEMBL276711
SEMAXANIB 🧪 Phase III
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase III
Basic Information
| ChEMBL ID | CHEMBL276711 |
| Name | SEMAXANIB |
| Phase | Phase III |
| Structure Type | MOL |
| InChI Key | WUWDLXZGHZSWQZ-WQLSENKSSA-N |
31
Targets
105
Activities
2
Assay Types
6
PK Parameters
20
Publications
6
Known Names
18
Indications
2
Mechanisms
Molecular Properties
238.3
MW (Da)
3.12
ALogP
1
HBA
2
HBD
44.9
PSA (Ų)
0.74
QED
0
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Stem cell growth factor receptor inhibitor | INHIBITOR | Mast/stem cell growth factor receptor Kit | ✓ | ✓ |
| Vascular endothelial growth factor receptor inhibitor | INHIBITOR | Vascular endothelial growth factor receptor | ✓ | ✓ |
Indications
Colorectal Neoplasms Colorectal Neoplasms Carcinoma, Renal Cell Kidney Neoplasms Melanoma Melanoma Mesothelioma Multiple Myeloma Neoplasms, Plasma Cell Prostatic Neoplasms, Castration-Resistant Sarcoma Uterine Cervical Neoplasms Breast Neoplasms Central Nervous System Neoplasms Colonic Neoplasms Head and Neck Neoplasms Neoplasms Rectal Neoplasms
Activity Summary
IC50 103 meas. best 8.51
EC50 2 meas. best 4.94
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MCF7 CHEMBL387 | IC50 | 8.51 | 7.115 | 3.1 | 2 |
| B16-F10 CHEMBL612656 | IC50 | 8.44 | 8.44 | 3.6 | 1 |
| PBMC CHEMBL613107 | IC50 | 8.3 | 8.3 | 5.0 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL1868 | IC50 | 8.1 | 7.09 | 8.0 | 4 |
| NON-PROTEIN TARGET CHEMBL3879801 | IC50 | 7.52 | 5.9514 | 30.0 | 7 |
| Mast/stem cell growth factor receptor Kit CHEMBL1936 | IC50 | 7.46 | 6.68 | 35.0 | 3 |
| HUVEC CHEMBL613979 | IC50 | 7.4 | 5.68 | 40.0 | 3 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.4 | 5.6384 | 40.0 | 31 |
| Vascular endothelial growth factor receptor 3 CHEMBL1955 | IC50 | 7.3 | 6.8 | 50.0 | 2 |
| Chorioallantoic membrane CHEMBL2367390 | IC50 | 7.22 | 6.17 | 60.0 | 3 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 7.17 | 5.6042 | 68.0 | 12 |
| Macrophage colony-stimulating factor 1 receptor CHEMBL1844 | IC50 | 7.08 | 7.08 | 84.0 | 1 |
| A-431 CHEMBL614069 | IC50 | 7.07 | 5.3075 | 85.0 | 4 |
| Gallus gallus CHEMBL613109 | IC50 | 7.07 | 7.07 | 85.0 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 6.8 | 6.8 | 160.0 | 2 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 6.77 | 6.77 | 170.0 | 1 |
| Platelet-derived growth factor receptor alpha CHEMBL2007 | IC50 | 6.7 | 6.7 | 200.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL3337 | IC50 | 5.98 | 5.98 | 1040.0 | 1 |
| Vascular endothelial growth factor receptor 1 CHEMBL3516 | IC50 | 5.98 | 5.98 | 1040.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.98 | 5.98 | 1040.0 | 1 |
| ALK tyrosine kinase receptor CHEMBL4247 | IC50 | 5.92 | 5.83 | 1200.0 | 2 |
| Platelet-derived growth factor receptor CHEMBL2096980 | IC50 | 5.39 | 4.9233 | 4050.0 | 3 |
| Fibroblast growth factor receptor 1 CHEMBL3650 | IC50 | 5.38 | 4.995 | 4200.0 | 4 |
| Fibroblast growth factor receptor CHEMBL2095217 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.1 | 5.1 | 7943.3 | 1 |
| Tyrosine-protein kinase ABL1 CHEMBL1862 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Oxytocin receptor CHEMBL2049 | EC50 | 4.94 | 4.94 | 11468.0 | 1 |
| Vasopressin V1a receptor CHEMBL1889 | EC50 | 4.92 | 4.92 | 12070.0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 4.79 | 4.79 | 16400.0 | 1 |
| HeLa CHEMBL399 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Tyrosine-protein kinase ZAP-70 CHEMBL2803 | IC50 | 4.68 | 4.68 | 20700.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 45.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 52.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 14.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 25.7 | mL.min-1.kg-1 | Macaca |
| Cmax | 300000.0 | nM | Mus musculus |
| Tmax | 0.5 | hr | Mus musculus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16621936 | 10.1124/dmd.105.006619 | ADMET | 8 |
| 30098912 | 10.1016/j.bmc.2018.07.037 | Danio rerio | 5 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 26318056 | 10.1016/j.ejmech.2015.08.027 | Aorta | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 10893303 | 10.1021/jm9906116 | HUVEC | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| 10602697 | 10.1021/jm9904295 | Vascular endothelial growth factor receptor 2 | 3 |
| 23124213 | 10.1016/j.ejmech.2012.10.001 | NON-PROTEIN TARGET | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 3 |
| 12477352 | 10.1021/jm020899q | Vascular endothelial growth factor receptor 2 | 3 |
| 27894589 | 10.1016/j.bmc.2016.11.026 | Unchecked | 3 |
| 12477352 | 10.1021/jm020899q | Fibroblast growth factor receptor 1 | 3 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
Data from ChEMBL 36 via Core Engine